Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Most studies on hospital-acquired pneumonia (HAP) have been conducted in intensive care unit (ICU) settings. This study aimed to investigate the microbiological and clinical characteristics of non-ICU-acquired pneumonia (NIAP) and to identify the factors affecting clinical outcomes in Korea. Methods: This multicenter retrospective cohort study was conducted in patients admitted to 13 tertiary hospitals between July 1, 2019 and December 31, 2019. Patients diagnosed with NIAP were included in this study. To assess the prognostic factors of NIAP, the study population was classified into treatment success and failure groups. Results: Of 526 patients with HAP, 379 were diagnosed with NIAP. Overall, the identified causative pathogen rate was 34.6% in the study population. Among the isolated organisms (n = 113), gram-negative bacilli were common pathogens (n = 91), such as Pseudomonas aeruginosa (n = 25), Acinetobacter baumannii (n = 23), and Klebsiella pneumoniae (n = 21). The multidrug resistance rates of A. baumannii, P. aeruginosa, and K. pneumoniae were 91.3%, 76.0%, and 57.1%, respectively. Treatment failure was significantly associated with K. pneumoniae (odds ratio [OR], 3.50; 95% confidence interval [CI], 1.35 to 9.05; p = 0.010), respiratory viruses (OR, 3.81; 95% CI, 1.34 to 10.82; p = 0.012), hematological malignancies (OR, 3.54; 95% CI, 1.57 to 8.00; p = 0.002), and adjunctive corticosteroid treatment (OR, 2.40; 95% CI, 1.27 to 4.52; p = 0.007). Conclusions: The causative pathogens of NIAP in Korea are predominantly gram-negative bacilli with a high rate of multidrug resistance. These were not different from the common pathogens of ICU-acquired pneumonia.
Abstract
Background/Aims: Most studies on hospital-acquired pneumonia (HAP) have been conducted in intensive care unit (ICU) settings. This study aimed to investigate the microbiological and clinical characteristics of non-ICU-acquired pneumonia (NIAP) and to identify the factors affecting clinical outcomes in Korea. Methods: This multicenter retrospective cohort study was conducted in patients admitted to 13 tertiary hospitals between July 1, 2019 and December 31, 2019. Patients diagnosed with NIAP were included in this study. To assess the prognostic factors of NIAP, the study population was classified into treatment success and failure groups. Results: Of 526 patients with HAP, 379 were diagnosed with NIAP. Overall, the identified causative pathogen rate was 34.6% in the study population. Among the isolated organisms (n = 113), gram-negative bacilli were common pathogens (n = 91), such as Pseudomonas aeruginosa (n = 25), Acinetobacter baumannii (n = 23), and Klebsiella pneumoniae (n = 21). The multidrug resistance rates of A. baumannii, P. aeruginosa, and K. pneumoniae were 91.3%, 76.0%, and 57.1%, respectively. Treatment failure was significantly associated with K. pneumoniae (odds ratio [OR], 3.50; 95% confidence interval [CI], 1.35 to 9.05; p = 0.010), respiratory viruses (OR, 3.81; 95% CI, 1.34 to 10.82; p = 0.012), hematological malignancies (OR, 3.54; 95% CI, 1.57 to 8.00; p = 0.002), and adjunctive corticosteroid treatment (OR, 2.40; 95% CI, 1.27 to 4.52; p = 0.007). Conclusions: The causative pathogens of NIAP in Korea are predominantly gram-negative bacilli with a high rate of multidrug resistance. These were not different from the common pathogens of ICU-acquired pneumonia.
참고문헌 (16)
- American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Flanders SA, "Nosocomial pneumonia : state of the science", Am J Infect Control, 34, pp.84~93 (2006)
- Di Pasquale M, "Non-intensive care unit acquired pneumonia : a new clinical entity?", Int J Mol Sci, 17, pp.287~ (2016)
- Sopena N, "Risk factors for hospital-acquired pneumonia outside the intensive care unit : a case-control study", Am J Infect Control, 42, pp.38~42 (2014)
- Herer B, "Management of nosocomial pneumonia on a medical ward : a comparative study of outcomes and costs of invasive procedures", Clin Microbiol Infect, 15, pp.165~172 (2009)
- Kalil AC, "Management of adults with hospital-acquired and ventilator-associated pneumonia : 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society", Clin Infect Dis, 63, pp.e61~e111 (2016)
- Singer M, "The third international consensus definitions for sepsis and septic shock(Sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Basak S, "Multidrug resistant and extensively drug resistant bacteria : a study", J Pathog, 2016, pp.4065603~ (2016)
- Ko Ryoung-Eun, "Characteristics, Management, and Clinical Outcomes of Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: A Multicenter Cohort Study in Korea", Tuberculosis and Respiratory Diseases, 84(4), pp.317~325 (2021), 대한결핵및호흡기학회[DOI]
- Weber DJ, "Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia", Infect Control Hosp Epidemiol, 28, pp.825~831 (2007)
- Lee HS, "Pneumonia in hospitalized neurologic patients : trends in pathogen distribution and antibiotic susceptibility", Antimicrob Resist Infect Control, 8, pp.25~ (2019)
- Chung DR, "High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia", Am J Respir Crit Care Med, 184, pp.1409~1417 (2011)
- Sucher A, "Updated IDSA", ATS guidelines on management of adults with HAP and VAP, 2017, pp.42, 12~21
- Juan CH, "Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains : a retrospective study", Antimicrob Resist Infect Control, 9, pp.4~ (2020)
- Johansson N, "Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia", Scand J Infect Dis, 43, pp.609~615 (2011)
- Voiriot G, "Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia", Crit Care, 20, pp.375~ (2016)